T1	Pharmacological_substance 10 21	Ticlopidine
N1000 	Reference T1 MeSH:D013988	Ticlopidine
T2	Pharmacological_substance 58 70	cyclosporine
N1001 	Reference T2 MeSH:D016572	cyclosporine
T3	Disorder 87 95	diabetic
N1 	Reference T3 UMLS:C0011860	diabetic
N2 	Reference T3 UMLS:C0011849	diabetic
T4	Disorder 100 112	hypertensive
N3 	Reference T4 UMLS:C0020538	hypertensive
T5	Pharmacological_substance 146 157	ticlopidine
N1002 	Reference T5 MeSH:D013988	ticlopidine
T6	Pharmacological_substance 236 251	corticosteroids
N1003 	Reference T6 MeSH:D000305	corticosteroids
T7	Pharmacological_substance 292 304	cyclosporine
N1004 	Reference T7 MeSH:D016572	cyclosporine
T8	Pharmacological_substance 348 359	ticlopidine
N1005 	Reference T8 MeSH:D013988	ticlopidine
T9	Pharmacological_substance 464 479	corticosteroids
N1006 	Reference T9 MeSH:D000305	corticosteroids
T10	Pharmacological_substance 630 642	cyclosporine
N1007 	Reference T10 MeSH:D016572	cyclosporine
T11	Pharmacological_substance 679 694	corticosteroids
N1008 	Reference T11 MeSH:D000305	corticosteroids
T12	Pharmacological_substance 696 708	cyclosporine
N1009 	Reference T12 MeSH:D016572	cyclosporine
T13	Disorder 30 44	marrow aplasia
N4 	Reference T13 UMLS:C1368107	marrow aplasia
T16	Subject 113 125;73 86	male patient A 50-year-old
T14	Disorder 166 180	marrow aplasia
N5 	Reference T14 UMLS:C1368107	marrow aplasia
T17	Pharmacological_substance 205 231	colony-stimulating factors
N1010 	Reference T17 MeSH:D003115	colony-stimulating factors
T15	Disorder 368 382	marrow aplasia
N6 	Reference T15 UMLS:C1368107	marrow aplasia
T18	Subject 748 766	resistant patients
T19	Pharmacological_substance 433 459	colony-stimulating factors
N1011 	Reference T19 MeSH:D003115	colony-stimulating factors
T26	Manner_cue 181 190	partially
T27	Manner_cue 269 277	complete
T31	Manner_cue 547 565	did not completely
T38	Coreferring_mention 577 594	these medications
T40	Coreferring_mention 534 541	patient
T39	Manner_cue 604 616	successfully
T34	Combination 662 673	combination
